Privacy Policy
Signals Blog

Contributors

Categories

After agonizing delay, UK rejoins Horizon Europe funding scheme

Anis Fahandej-Sadi is a Business Development Associate at OmniaBio Inc., with more than three years’ business development experience across laboratory and GMP instrumentation, and now manufacturing services in the cell and gene therapy space. After receiving his...

10 days ago in Toronto….

The 10-year boom of the cell and gene therapy (CGT) industry has inevitably come to an end: public CGT valuations are way down, companies are settling into cash conservation mode, unrealistic salary demands are being replaced by layoffs, and the vultures circling with...

Hope vs hype and champions vs charlatans

If you are reading all or parts of this blog carnival you are probably a fan of stem cells and regenerative medicine more broadly. You probably believe this field can and will change the way medicine is practiced. But how careful are you when choosing your words to...